ORIGINAL RESEARCH article
Front. Mol. Neurosci.
Sec. Brain Disease Mechanisms
Volume 18 - 2025 | doi: 10.3389/fnmol.2025.1564870
Changes in glycinergic neurotransmission alters mammalian retinal information processing
Provisionally accepted- 1Department of Ophthalmology, University Hospital Erlangen, Erlangen, Bavaria, Germany
- 2Animal physiology, Department of Biology, University of Erlangen Nuremberg, Erlangen, Bavaria, Germany
- 3Department of Biochemistry, University of Erlangen Nuremberg, Erlangen, Bavaria, Germany
- 4Department of Anesthesiology and Intensive care therapy, Leipzig University, Leipzig, Lower Saxony, Germany
- 5Department of Ophthalmology, Rabin Medical Center, Petah-Tikva, Israel
- 6Department of Ophtalmology, Rabin Medical Center, Petah-Tikva, Israel
- 7The Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Haifa, Israel
- 8Department of Ophtalmology, Rambam Health Care Campus, Haifa, Haifa, Israel
- 9The Genetics Institute and Genomic Center, Tel Aviv Sourasky Medical Center, Tel Aviv, Tel Aviv, Israel
- 10School of Medicine, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
- 11Translational Anesthesiology and Intensive Care, University of Augsburg, Augsburg, Germany
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Glycine, along with GABA, constitutes the major inhibitory neurotransmitter in the central nervous system (Kremers et al., 1993). In the retina, glycinergic neurotransmission is primarily used by amacrine cells that are involved in the lateral processing of visual stimuli in the inner retina. We have previously shown that the high-affinity glycine transporter 1 (GlyT1), that is commonly used as a reliable marker for glycinergic amacrine cells in the retina, is essential for glycinergic neurotransmission by these cells. Abolishment of retinal GlyT1 expression results in a breakdown of glycinergic neurotransmission by AII amacrine cells, but most likely also by other glycinergic amacrine cell populations. However, the impact of loss of glycinergic neurotransmission on retinal signal processing and visually guided behavior, has not yet been elucidated.In this study, the effects of loss of retinal GlyT1 expression in glycinergic amacrine cells on the optomotor reflex and on the photopic and scotopic electroretinogram (ERG) responses were analyzed.We show that retinal GlyT1-deficient mice have normal optomotor responses to rotating black and white stripes. When stimuli with sawtooth luminance profiles were used, thereby differentiating differentially activatingbetween ON and OFF pathwaysspecific responses, the GlyT1 deficient mice showed facilitated responses to ON preferring stimuli, whereas responses to OFF preferring stimuli were unchanged. These findings were corroborated by ERG recordings that showed undistinguishable responses after flash stimulation but revealed differences in the differential processing of ON and OFF preferring stimuli.To determine if the function of retinal GlyT1 is conserved in humans, we analyzed ERG recordings from a patient diagnosed with GlyT1 encephalopathy. We show that GlyT1 deficiency results in marked ERG changes, characterized by an almost complete loss of the "photopic hill" phenomenon, a hill-like appearance of the relationship between the b-wave amplitude and log light stimulus strength under background illumination conditions, and reductions in the ERG oscillatory potentials in the darkand light-adapted states. Both findings are consistent with an altered interaction between ON-and OFF pathways in the retina.Taken together our data show that glycinergic neurotransmission in the retina has important functions in retinal ON and OFF processing both in mice and humans.
Keywords: Glycine, synaptic inhibition, Retina, Amacrine Cells, Mouse, human
Received: 22 Jan 2025; Accepted: 24 Apr 2025.
Copyright: © 2025 Joachimsthaler, Hauf, Armbruster, Zayit -Soudry, Naaman, Perlman, Leibu, Kurolap, Baris-Feldman, Kremers and Eulenburg. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Volker Eulenburg, Translational Anesthesiology and Intensive Care, University of Augsburg, Augsburg, 91054, Germany
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.